The Bronchoscopes Market is estimated to be valued at USD 570.1 million in 2025 and is projected to reach USD 876.9 million by 2035, registering a compound annual growth rate (CAGR) of 4.4% over the forecast period.
| Metric | Value |
|---|---|
| Bronchoscopes Market Estimated Value in (2025 E) | USD 570.1 million |
| Bronchoscopes Market Forecast Value in (2035 F) | USD 876.9 million |
| Forecast CAGR (2025 to 2035) | 4.4% |
The bronchoscopes market is experiencing accelerated evolution driven by the rising global incidence of chronic respiratory disorders, advancements in minimally invasive diagnostics, and healthcare infrastructure upgrades. Increasing investments in pulmonology-focused medical devices, rising demand for early-stage detection of lung diseases, and the availability of technologically advanced visualization platforms are shaping demand dynamics.
Enhanced reimbursement structures in developed markets and expanded bronchoscopy training programs have improved the adoption of next-generation bronchoscopic systems. Growth in outpatient procedures, driven by the demand for real-time visualization and quicker recovery, continues to propel innovation in both rigid and flexible scopes.
Regulatory clearances for AI-assisted navigation and 3D imaging in bronchoscopy are expected to further transform clinical outcomes, paving the way for broader procedural adoption and precision medicine integration.
The market is segmented by Product, Modality, and End User and region. By Product, the market is divided into Video Bronchoscopes and Non-Video Bronchoscopes. In terms of Modality, the market is classified into Flexible Fiber Bronchoscopes, Rigid Bronchoscopes, and Mobile Bronchoscopes. Based on End User, the market is segmented into Hospitals and Outpatient Centers. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
Video bronchoscopes are expected to dominate the market with 58.40% of the total revenue share in 2025. This segment’s leadership has been fueled by the enhanced image resolution, real-time visualization, and digital integration capabilities provided by video technology.
The shift away from conventional optical systems toward video-enabled scopes has enabled improved clinical accuracy, data archiving, and collaborative diagnosis, especially in tertiary care settings. Compatibility with image-guided surgical systems and reduced risk of cross-contamination due to single-use options have further strengthened their positioning.
As healthcare providers prioritize workflow efficiency and infection control, video bronchoscopes continue to gain prominence across pulmonology departments globally.
Flexible fiber bronchoscopes are projected to hold 46.70% of the revenue share in 2025, making them the leading modality. Their popularity is rooted in their ability to navigate deep into the bronchial tree with minimal patient discomfort.
Their lightweight and maneuverable construction has made them essential for bedside and emergency diagnostics, particularly in intensive care units. Although video scopes are rising in adoption, flexible fiber scopes remain crucial in cost-sensitive and resource-limited settings due to their lower acquisition and maintenance costs.
Their continued use in diagnostic and therapeutic interventions, including bronchoalveolar lavage and foreign body removal, ensures strong demand across diverse clinical environments.
Hospitals are projected to account for 71.90% of the overall revenue in 2025, positioning them as the dominant end user of bronchoscopes. This prominence is supported by their comprehensive procedural infrastructure, access to specialized respiratory care units, and higher patient volumes for bronchoscopy procedures.
Hospitals typically house multidisciplinary teams equipped to perform both diagnostic and interventional bronchoscopies, which drives equipment procurement and utilization. Integration of advanced imaging platforms and compatibility with electronic health records (EHR) systems further enhances procedural accuracy and documentation within hospital settings.
As healthcare systems expand their surgical capabilities and adopt hybrid operating models, hospitals are expected to maintain their lead in bronchoscopic equipment usage.
| Particulars | Details |
|---|---|
| H1 - 2024 | 4.34% |
| H1 - 2025 Projected | 4.37% |
| H1 - 2025 Outlook | 4.27% |
| BPS Change - H1, 2025 (O) - H1, 2025 (P) | (-) 10 ↓ |
| BPS Change - H1, 2025 (O) - H1, 2024 | (-) 07 ↓ |
The bronchoscopes market is under influence of healthcare expenditure and innovation factors subject to macro and industry factors. Key developments in the market include acquisition and product launches by key players to establish their presence.
According to Future Market Insights analysis, the bronchoscopes market is expected to witness a drop in growth rate by 07 Basis Point Share (BPS) in H1- 2025 (O) as compared to H1-2024.
Main reason behind this drop can be attributed to growing stringency of regulations for the bronchoscope manufacturers, together with growing concern among end users regarding risks of cross-contamination and post bronchoscopy infection. H1-2025 outlook period in comparison to H1-2025 projected period showed a negative growth in terms of Basis Point Share by 10 BPS.
However, improved access to healthcare services and rise in demand for quality healthcare make the emerging markets highly lucrative for the medical device companies.
In particular, China is witnessing an increase in bronchoscopy procedure adoption since China offers lucrative reimbursement opportunities which attract more patients to avail the benefits associated with this procedure. In western countries as well, the rising geriatric population are also prone to increasing rate of the respiratory blockage related issues. Such factors can positively fuel the growth of bronchoscopes market.
According to Future Market Insights (FMI), the demand for bronchoscopes expanded at a CAGR of 4.1% during the period of 2013-2024. Rising demand for bronchoscopes can be attributed to the rising incidence of pulmonary diseases, increased life expectancy, and technological advancements in the field of bronchoscopy.
The advent of advanced bronchoscopy procedures such as Electromagnetic navigation bronchoscopy (ENB) is intended to enhance standard bronchoscopy by providing a three -dimensional roadmap of the lungs and real -time information about the position of the steerable probe during bronchoscopy. The electromagnetic navigation bronchoscopy is expected to secure higher reimbursement which will drive the demand for this market over the forecast period.
The improvement of healthcare infrastructure led to improved accessibility to healthcare, which in turn led to increased life expectancy and higher median age of the population. For instance, according to the World Health Organization (WHO) statistics, in 2024, the geriatric population was expected to outnumber children below 5 years of age. The proportion of population above 60 years of age would nearly be 22% by 2050. The most common conditions that geriatric population suffers from consist of COPD, diabetes, dementia and many others. Thus, the increasing geriatric population will positively impact the growth of this industry over the forecast period.
The key players of this industry are adopting strategies of acquisitions and product launches to expand their market existence and strengthen their foothold around the world.
The market is consolidated with players such as Olympus Corporation, Fujifilm Holdings Corporation, Teleflex Incorporated, Karl Storz GmbH & Co KG, Richard Wolf GmbH, Hoya Corporation (Pentax medical), Ambu A/S, Shanghai AoHua Photoelectricity Endoscope Co. Ltd., and Rochling Group.
Future Market Insights expects the global endoscopes market to expand at a CAGR of 4.4% over the forecast period owing to the efforts taken by the key players of this industry to expand themselves in the global market.
Most of the major medical device players are focusing on the emerging markets due to huge growth potential and to increase their distribution channel. Change in disease patterns triggered by lifestyle changes, rising affluence, improved access to healthcare services and rise in demand for quality healthcare make the emerging markets highly lucrative for the medical device companies.
Increasing elderly population represents additional opportunities for bronchoscopes manufacturers. In addition, reimbursement schemes in most developed countries is expected to fuel the demand for bronchoscopes in China over the forecast period.
Most of the major medical device players are focusing on cost reduction which has resulted in pricing pressure especially in the lower end devices. The market represents a bimodal nature with high end devices charging the premium. It also represents better use of technology and resources of the company.
Distribution efficiency represents another neglected area. Vendors need to develop specialized chains with the end user such as hospitals. Large healthcare providers and hospitals represent a large opportunity. The consolidation of healthcare especially in the U.S. provides a compelling opportunity to address the issues at the earliest.
Risks of cross-contamination and post bronchoscopy infection from bronchoscopy procedures is under research and is dampening the procedure adoption rates. The risks of bronchoscopy such as bleeding, trouble breathing and a low blood oxygen level during the test are also hampering the market.
The rates of a patient having a post bronchoscopy infection is rising due to the emergence of methicillin resistant staphylococcus aureus and other resistant bacteria. The post bronchoscopy infection rates at ambulatory surgical centres (ASCs) are many times higher than hospitals and clinics, which is hampering the bronchoscopes market.
Emergence of non-invasive diagnostic methods such as liquid biopsy, Magnetic Resonance Spectroscopy and others is negating the market growth. Growing stringency of regulations such as Post Marketing Approval is hampering the market. Bringing a device to market takes an average of 3 to 7 years.
Class III devices require pre-market approval (PMA), the most rigorous process required for devices by the FDA. Such devices will require clinical evidence to support the application owing to significantly greater risks to patients. Thus the growing stringency of regulations is hampering the growth of this industry.
USA is expected to hold 91.8% market share of North America region, by value in the year 2024 and is anticipated to expand at a CAGR of 4.2% over the forecast period 2025-2035 owing to aspects such as an increase in the number of hospitals, development of healthcare infrastructure, an increase in healthcare spending, the growth of the aging population, presence of a large patient population.
Additionally, favourable reimbursement scenarios in the USA are positively affecting the demand of bronchoscopes and is expected to follow similar trend over the forecast period.
In Europe, Germany is expected to account for 19.1% share, by value of the total European bronchoscopes market, by the end of 2024. Increased adoption of minimally invasive surgeries, and technological advancements in the field of bronchoscopy are some of the key factors that will propel the demand of bronchoscopes in Germany.
India is anticipated to hold 19.5% share, by value of the total Asia Pacific bronchoscopes market, by value in 2024 and will expand at a CAGR of 6.4% over the forecast period. High prevalence of chronic pulmonary diseases, and increasing healthcare expenditure by the government, and increased adoption of bronchoscopy are some of the key factors driving the demand for bronchoscopes in India.
The global bronchoscopes market is expected to register sales worth USD 546.1 Million by the end of 2024 and is projected to reach USD 876.9 Mn by the end of 2035 with a cumulative CAGR of 4.4%.
Video bronchoscopes is expected to 86.4% market share, by value by the end of 2024, and will expand at a CAGR of 4.2% over the forecast period. Since video bronchoscopes are widely used for the diagnosis of infectious diseases, inflammatory conditions or tumours of the lung, they contribute to the largest market share of this market.
Flexible fiber bronchoscopes have high-definition recordings, allowing for easy detection of cancers and infections in the bronchioles' deeper levels. Flexible bronchoscopes are convenient for both doctors and patients as it takes substantially less time to recover from than rigid bronchoscopy and are expected to register sales worth USD 450.4 Million by the end of 2024, which would account for more than 93% share, by value of the total bronchoscopes market and is expected to expand at a CAGR of 4.4% between 2025 and 2035.
Hospitals are expected to hold the highest share of 64.5%, by value in 2024, and will expand to reach USD 421.3 Million by the end of 2035. The segment is set to expand at a CAGR of 4.4% over the forecast period, owing to the high preference for hospital-based treatment & procedures, availability of skilled healthcare professionals, technologically advanced facilities, and favorable reimbursement scenario.
Key manufacturers of the bronchoscopes market are focusing on gaining approvals from various regulatory authorities, expanding their business in new regions, and collaborating with other leading players in order to strengthen their product portfolio and market presence all over the world.
The increasing demand for bronchoscopy procedures, higher prevalence rates of chronic pulmonary disorders will offer many opportunities for the key players.
| Attribute | Details |
|---|---|
| Forecast Period | 2025 to 2035 |
| Historical Data Available for | 2013 to 2024 |
| Market Analysis | USD Million for Value. |
| Key Countries Covered | USA, Canada, Germany, UK, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
| Key Segments Covered | Product, Modality, End-User and Region. |
| Key Companies Profiled | Olympus Corporation; Fujifilm Holdings Corporation; Teleflex Incorporated; Karl Storz GmbH & Co KG; Richard Wolf GmbH; Hoya Corporation (Pentax medical); Ambu A/S; Shanghai AoHua Photoelectricity Endoscope Co. Ltd.; Rochling Group |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global bronchoscopes market is estimated to be valued at USD 570.1 million in 2025.
The market size for the bronchoscopes market is projected to reach USD 876.9 million by 2035.
The bronchoscopes market is expected to grow at a 4.4% CAGR between 2025 and 2035.
The key product types in bronchoscopes market are video bronchoscopes and non-video bronchoscopes.
In terms of modality, flexible fiber bronchoscopes segment to command 46.7% share in the bronchoscopes market in 2025.
Explore Similar Insights
Bronchoscopes Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
